Over the course of the forecast period, the main market players are anticipated to increase their research and development efforts in order to produce medications for irritable bowel syndrome. For instance, on June 9, 2022, the biopharmaceutical company Ferring B.V. announced a strategic partnership with the innovation-focused global biopharma company I-MAB Biopharma Co., Ltd. to advance the development of olamkicept, a selective interleukin-6 (IL-6) trans-signaling inhibitor for inflammatory bowel disease (IBD) and associated inflammatory conditions.
The global Irritable Bowel Syndrome Treatment Market is estimated to be valued at US$ 1,444.7 million in 2022 and is expected to exhibit a CAGR of 13.2% during the forecast period (2022-2030).
Leading Companies in the Irritable Bowel Syndrome Treatment Industry:
1. Abbott
Abbott is a global healthcare leader in medical products and devices manufacturing. It serves people in more than 160 countries. Abbott was established in 1888. Abbott launched its Navitor its latest generation transcatheter aortic valve implantation (TAVI) system to treat Aortic Stenosis in India.
2. Synergy Pharma
Synergy Pharma is a speciality pharmaceuticals company that deals with medical devices, prescription strength vitamins since 2009. The headquarters of Synergy Pharma are situated in Dubai, UAE.
3. Mallinckrodt
Three brothers in 1867 established Mallinckrodt. The headquarters are situated in Dublin, Ireland. Received FDA approval for Terlivaz (terlipressin) for injection, the first and only FDA-approved treatment for adults with hepatorenal syndrome (HRS) involving rapid reduction in Kidney function in 2022.
4. Bausch Health Companies Inc.
Bausch Health Companies Inc. is a global company that develops, manufactures and markets a range of pharmaceuticals.The headquarters are located in Quebec, Canada and is operational in more than 90 countries.
5. Astellas Pharma Inc.
Astellas Pharma Inc. was established in the yesr 2005.Its headquarter is located in Northbook, IL. Astellas supported recommendations of Task Force on Climate-related financial Disclosur in 2020.
6. Novartis AG
Novartis is structured and well developed company that helps deliver innovative products, and respond to new opportunities and risks. Headquarters is located in Basel, Baselstadt.
7. GSK plc.
GSK has headquarters situated in Brentford, Middlesex.
GSK and Wave life sciences announce collaboration to drive discovery and development of oligonucleotide therapeutic focusing on novel genetic target in December 2022.
8. Ironwood Pharmaceuticals
Since 1998 Ironwood Pharmaceuticals is leading treatment of GI diseases and redefining the standard for GI patients. Headquarters are situated in Boston, MA.
9. Takeda Pharmaceutical Company Limited.
Since 1781 Takeda is a patient focused, values based, R&D driven global biopharmaceutical company. Headquarters are located Mumbai, India.
*Definition-The digestive tract illness called irritable bowel syndrome is characterised by abdominal pain and irregular stool movements.
